Precigen

PGENNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.589 B

$7.23 +4.63%

Close of 7 Aug 2026

Revenue

$9.68M

#3177 by revenue

Earnings

-$250.6M

Loss-making

Shares outstanding

358,035,247

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#88Zai LabZLAB$2.62B
#89Prestige Consumer HealthcarePBH$2.60B
#90PrecigenPGEN$2.59B
#91Nektar TherapeuticsNKTR$2.58B
#92Ultragenyx PharmaceuticalRARE$2.55B

Where these numbers come from

Share counts and financials for Precigen are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.